By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777



Company News
Prima Biomed (PRR.AX) Completes Recruitment For Second Patient Cohort In Melanoma Trial And Will Present At ICI Conference In Boston 3/15/2017 12:04:30 PM
Prima Biomed (PRR.AX) Release: U.S.A. Patent Grants For IMP321 In Cancer 3/1/2017 11:43:29 AM
Prima Biomed (PRR.AX) Receives ~A$860,000 Tax Credit Payment From French Government 2/14/2017 11:36:47 AM
Prima Biomed (PRR.AX) Release: Company Commences Randomised Phase IIb Clinical Trial For IMP321 In Breast Cancer 1/20/2017 11:40:07 AM
Prima Biomed (PRR.AX) Release: Company Commences Recruitment For Second Cohort Of Melanoma Trial 1/12/2017 10:03:02 AM
Prima Biomed (PRR.AX) Enters New Material Transfer Agreement With CYTLIMIC 1/5/2017 8:23:43 AM
Prima Biomed (PRR.AX) Announces New Product Candidate IMP761 — A LAG-3 Agonist Antibody 1/3/2017 10:12:53 AM
Prima Biomed (PRR.AX) Announces First Clinical Data From Combination Of IMP321 With Anti-PD1 12/29/2016 7:26:40 AM
Prima Biomed (PRR.AX) Announces Data From IMP321 AIPAC Clinical Trial In Breast Cancer 12/22/2016 9:04:04 AM
Prima Biomed (PRR.AX) Receives UK Approval For AIPAC Study 12/20/2016 1:20:36 PM